Logo Hyperdream
BOOKS

NeuroSplice™ K-Series

CLINICAL INVESTIGATION NSK-2024-07 // PARIS

Dream. Record. Relive.

The NeuroSplice K-Series records your brain activity during REM sleep. It can also introduce images, sounds, and sensations prescribed by your physician.

Tomorrow, a dream on prescription?

We are looking for a limited number of volunteers. Participation is compensated.

NeuroSplice K-Series console
Play video

Why the NeuroSplice K-Series?

Unlock the untapped potential of your subconscious and reach a new level of control over your dreamscape.

Record

The DreamShare module captures cortical activity during REM sleep. The console at the foot of the bed turns it into images.

Relive

The DreamCast module introduces scenes chosen by the physician into the dream, in fragments and at decreasing intensity.

Heal

Dream therapies are intended for treatment-resistant post-traumatic stress, disabling phobias, complicated grief, and treatment-resistant depression.

Safeguard

Injection is limited to twelve minutes per REM cycle. A safety system shuts it down in the event of a loop.

How it works

From the screening visit to your first recorded night.

1 Assessment and implantation

After a full assessment at the center (MRI, EEG, sleep recording), the device is implanted under general anesthesia. The procedure takes about three hours. The housing sits behind the ear.

2 Calibration

For forty-eight hours, the onboard artificial intelligence learns your sleep signature.

3 Sessions

Recordings take place at night, from 10 p.m. to 4 a.m. The study physician schedules the injection sessions, never more than twelve minutes per cycle.

// NEUROSPLICE K-SERIES CLINICAL CONSOLE

>Implant initialization, revision 2.1 β... OK

>Encrypted link to clinical console (TLS-Q13)... OK

>ECoG array, 256 channels... OK

>Implant/console latency: 38 ms

>Anti-loop watchdog (0x7E)... ACTIVE

>Subject: awaiting enrollment

>_

System statusNominal
Dream coherence82%
Recording window22:00 - 04:00
Self-testNo anomaly detected

The first results are in.

Pilot cohort (48 patients): 41% average reduction in post-traumatic symptoms at six weeks.

They took part

Testimonials from patients in the pilot cohort and from study volunteers. First names have been replaced with an initial.

L.

Patient L., 41

Pilot cohort

“I saw the scene from a distance, as if it belonged to someone else. Since then, I’ve been able to talk about it.”

M.

Patient M., 29

Pilot cohort

“I’d been afraid of elevators since grade school. On Tuesday, I rode up to the sixth floor for my appointment. It was only when I stepped out that I realized I’d taken the elevator.”

R.

Volunteer R., 33

Healthy volunteer

“In the morning, the nurse showed me my night on the console. There was my grandmother’s kitchen, with the checkered oilcloth. I hadn’t seen it in twenty years.”

Who can take part?

The program selects its volunteers after a full medical assessment and an implant compatibility exam.

Profiles we are looking for

  • Healthy volunteers with a technical background

    Developers, engineers, researchers. You will be among the first to see your dreams on a screen.

  • Sleep disorders

    Chronic insomnia, recurring nightmares.

  • Patients referred by their physician

    Treatment-resistant post-traumatic stress, disabling phobia, complicated grief, treatment-resistant depression.

  • Frequent dreamers

    You remember your dreams almost every morning, or you sometimes know you are dreaming while you dream.

Contraindications

  • Psychiatric disorders

    Schizophrenia, dissociative disorders, severe bipolar disorder.

  • Neurological history

    Epilepsy, stroke, head injury within the past eighteen months, neurodegenerative disease.

  • Anatomy

    An existing brain or metal implant. Parietal bone less than six millimeters thick.

  • Other situations

    Pregnancy. Use of non-prescribed psychoactive substances.

Before you apply

After implantation, MRI is contraindicated, whether the implant is active or on standby. CT scans remain possible.

Pre-screening form

A study physician reviews every application. Participation is compensated: €2,400 at implantation, then €80 per recorded night.

What is/are your main reason(s) for participating (check all that apply)

Fictional form. Nothing you enter is sent or stored: the form replies, then clears the fields.

Your questions

Is the implantation painful?

Implantation is performed under general anesthesia and takes about three hours. Some discomfort behind the ear is common for the first few days. It is treated with simple pain relievers.

Will I still dream normally?

Yes. Outside the sessions scheduled by the study physician, the NeuroSplice introduces no content into your dreams.

How does selection work?

After the pre-screening form, a study physician contacts you. A screening visit takes place at the center in Paris. You sign the consent form there, then you have a seven-day reflection period before implantation.

What are the risks?

Infection and hematoma, as with any intracranial surgery. The device also has specific effects: very persistent dreams, confusion on waking. In some volunteers, images can spill over into waking life. The medical team follows every volunteer closely during the first weeks.

Do my dreams stay private?

Data travels end-to-end encrypted between the implant and the clinical console. It is anonymized by aggregation before any use for research purposes.

Can I stop?

You may at any time request that recordings be stopped and that the implant be removed, subject to a favorable surgical opinion.

What happens if something goes wrong?

The safety system shuts down injection as soon as a sequence repeats. The medical team notifies your designated trusted person.

Is participation paid?

You receive €2,400 at implantation, then €80 per recorded night. This compensation covers the constraints of the study. It is neither a salary nor the price of your data.

Safety

Every session is supervised by the medical team of the neuro-interfaces department.

Injection quota

Twelve minutes maximum per REM cycle.

Anti-loop safety

The system shuts down injection as soon as a sequence repeats (code 0x7E).

Neuro-interfaces on-call team

A medical team can be reached day and night for the entire duration of the study.

Mandatory notices. Investigational device. Streams collected during sessions are stored and reused for the continuous improvement of the models, in accordance with the terms and conditions signed by the patient. Reported effects: persistent dreams, confusion on waking, sense of presence, intrusion of non-prescribed images.

Fictional website
Hyperdream and the NeuroSplice do not exist. This is not a medical website. Learn more